CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ERAS — Erasca, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ERAS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,628,552
+$4,915,288 QoQ
Shares Held
1,944,790
+2.5% QoQ
Ownership
0.556%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#29
of 257 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. ERAS ranks #43 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in ERAS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,628,552 | 1,944,790 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $30,713,264 | 1,898,224 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,225,062 | 1,673,404 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,761,276 | 1,725,356 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,154,673 | 1,696,593 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,975,068 | 1,441,656 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $4,424,366 | 1,762,696 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,705,509 | 1,723,630 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,146,873 | 1,333,421 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,367,572 | 663,870 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,384,787 | 650,135 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,264,028 | 641,639 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,602,726 | 580,698 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,652,754 | 549,088 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,956,765 | 454,006 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,492,645 | 447,775 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,267,626 | 227,581 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,062,606 | 239,838 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,189,395 | 140,526 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,830,641 | 133,395 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||